These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 9027781)

  • 21. Usefulness of preoperative Tc-mibi parathyroid scintigraphy in secondary hyperparathyroidism.
    de la Rosa A; Jimeno J; Membrilla E; Sancho JJ; Pereira JA; Sitges-Serra A
    Langenbecks Arch Surg; 2008 Jan; 393(1):21-4. PubMed ID: 17294211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. P-gp and MRP1 expression in parathyroid tumors related to histology, weight and (99m)Tc-sestamibi imaging results.
    Jorna FH; Hollema H; Hendrikse HN; Bart J; Brouwers AH; Plukker JT
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):406-12. PubMed ID: 19235131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistent secondary hyperparathyroidism caused by parathyromatosis and supernumerary parathyroid glands in a patient on haemodialysis.
    Yang J; Zhang J; Liu NH; Liu H; Dong MJ
    BMC Nephrol; 2020 Jul; 21(1):257. PubMed ID: 32631272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative imaging of parathyroid glands with technetium-99m-labelled sestamibi and iodine-123 subtraction scanning in secondary hyperparathyroidism.
    Hindié E; Urenã P; Jeanguillaume C; Mellière D; Berthelot JM; Menoyo-Calonge V; Chiappini-Briffa D; Janin A; Galle P
    Lancet; 1999 Jun; 353(9171):2200-4. PubMed ID: 10392985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Technetium-99m-sestamibi single agent localization versus high resolution ultrasonography for the preoperative localization of parathyroid glands in patients with primary hyperparathyroidism.
    Billy HT; Rimkus DR; Hartzman S; Latimer RG
    Am Surg; 1995 Oct; 61(10):882-8. PubMed ID: 7668462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tc-99m-MIBI scintigraphy for recurrent hyperparathyroidism after total parathyroidectomy with autograft.
    Itoh K; Ishizuka R
    Ann Nucl Med; 2003 Jun; 17(4):315-20. PubMed ID: 12932116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired Tc-99m MIBI uptake in the thyroid and parathyroid glands during early phase imaging in hemodialysis patients.
    Kiratli PO; Ceylan E; Naldöken S; Beylergil V
    Rev Esp Med Nucl; 2004; 23(5):347-51. PubMed ID: 15450141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy of technetium-99m-MIBI scan and intraoperative methylene blue staining for the localization of abnormal parathyroid glands.
    Takei H; Iino Y; Endo K; Horiguchi J; Maemura M; Koibuchi Y; Horii Y; Yokoe T; Ishida T; Oyama T; Morishita Y
    Surg Today; 1999; 29(4):307-12. PubMed ID: 10211559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective evaluation of the efficacy of technetium 99m sestamibi and iodine 123 radionuclide imaging of abnormal parathyroid glands.
    Wei JP; Burke GJ; Mansberger AR
    Surgery; 1992 Dec; 112(6):1111-6; discussion 1116-7. PubMed ID: 1455313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative evaluation of parathyroid lesions in patients with concomitant thyroid disease: role of high resolution ultrasonography and dual phase technetium 99m sestamibi scintigraphy.
    Kebapci M; Entok E; Kebapci N; Adapinar B
    J Endocrinol Invest; 2004 Jan; 27(1):24-30. PubMed ID: 15053239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting the effect of intravenous calcitriol on parathyroid gland activity using double-phase technetium Tc 99m-sestamibi scintigraphy.
    Torregrosa JV; Fuster D; Ybarra J; Ortín J; Moreno A; Valveny N
    Am J Kidney Dis; 2004 Sep; 44(3):476-80. PubMed ID: 15332220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The accuracy of parathyroid gland localization in primary hyperparathyroidism using sestamibi radionuclide imaging.
    Johnston LB; Carroll MJ; Britton KE; Lowe DG; Shand W; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1996 Jan; 81(1):346-52. PubMed ID: 8550776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Utility of 99m Tc MIBI gammagraphy before parathyroidectomy in patients with secondary hyperparathyroidism].
    Martín F; Sarró F; Verdú J; Martínez A
    Nefrologia; 2001; 21(2):221-2. PubMed ID: 11464660
    [No Abstract]   [Full Text] [Related]  

  • 34. Preoperative technetium Tc 99m sestamibi SPECT imaging in the management of primary hyperparathyroidism in patients with concomitant multinodular goiter.
    Lorberboym M; Ezri T; Schachter PP
    Arch Surg; 2005 Jul; 140(7):656-60. PubMed ID: 16027330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathologic and radiopharmacokinetic factors affecting gamma probe-guided parathyroidectomy.
    Ugur O; Bozkurt MF; Hamaloglu E; Sokmensuer C; Etikan I; Ugur Y; Sayek I; Gulec SA
    Arch Surg; 2004 Nov; 139(11):1175-9. PubMed ID: 15545562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Localization of abnormal parathyroid glands with jugular sampling for parathyroid hormone, and subtraction scanning with sestamibi or tetrofosmine.
    Pattou F; Oudar C; Huglo D; Racadot A; Carnaille B; Proye C
    Aust N Z J Surg; 1998 Feb; 68(2):108-11. PubMed ID: 9494000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parathyroid detection in secondary hyperparathyroidism with 123I/99mTc-sestamibi subtraction single photon emission computed tomography.
    Neumann DR; Esselstyn CB; Madera A; Wong CO; Lieber M
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3867-71. PubMed ID: 9814460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Technetium-99m-sestamibi/thallium-201 mismatch of thyroid and parathyroid adenoma in chronic renal failure.
    Pijpers R; van Loon BJ; Roos JC; Hoekstra OS
    J Nucl Med; 1995 May; 36(5):826-8. PubMed ID: 7738659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two-phase scintigraphy with technetium 99m-sestamibi in patients with hyperparathyroidism due to chronic renal failure.
    Muros MA; Bravo Soto J; López Ruiz JM; Rodríguez-Portillo M; Ramírez Navarro A; Bellón Guardia M; Perán F; Llamas-Elvira JM
    Am J Surg; 2007 Apr; 193(4):438-42. PubMed ID: 17368284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic resonance imaging (MRI) and technetium-99m-methoxyisonitrile (MIBI) scintigraphy to evaluate the abnormal parathyroid gland and PEIT efficacy for secondary hyperparathyroidism.
    Wada A; Sugihara M; Sugimura K; Kuroda H
    Radiat Med; 1999; 17(4):275-82. PubMed ID: 10510900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.